Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Jiangxi Rimag Group Co., Ltd. Class H ( (HK:2522) ) is now available.
Jiangxi Rimag Group Co., Ltd. announced that certain directors have increased their shareholding in the company, purchasing a total of 96,500 H shares. This decision reflects their confidence in the company’s recent achievements and strategic alignment with national policies on AI and healthcare, suggesting that the current share price undervalues the company’s long-term potential.
The most recent analyst rating on (HK:2522) stock is a Hold with a HK$16.00 price target. To see the full list of analyst forecasts on Jiangxi Rimag Group Co., Ltd. Class H stock, see the HK:2522 Stock Forecast page.
More about Jiangxi Rimag Group Co., Ltd. Class H
Jiangxi Rimag Group Co., Ltd. operates in the medical imaging industry, focusing on regional medical imaging sharing centers and medical imaging data services. The company is known for its comprehensive smart medical imaging industry chain, integrating data, AI algorithms, and application scenarios.
Average Trading Volume: 19,846,865
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.33B
See more data about 2522 stock on TipRanks’ Stock Analysis page.